Home/Filings/4/0001415889-25-023742
4//SEC Filing

Feider Stephen 4

Accession 0001415889-25-023742

CIK 0001674632other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 6:45 PM ET

Size

5.2 KB

Accession

0001415889-25-023742

Insider Transaction Report

Form 4
Period: 2025-09-02
Feider Stephen
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-09-02$18.86/sh1,462$27,57844,041 total
Footnotes (2)
  • [F1]The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • [F2]The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Issuer

Beta Bionics, Inc.

CIK 0001674632

Entity typeother

Related Parties

1
  • filerCIK 0002048588

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 6:45 PM ET
Size
5.2 KB